CombiMatrix (Nasdaq: CBMX) 194.9% HIGHER; announced that a pair of studies published in a leading journal favor chromosomal microarray analysis (CMA) over traditional karyotyping for genetic prenatal diagnosis and genetic evaluation of stillbirths.

Amarin Corporation plc (Nasdaq: AMRN) 18.9% LOWER; announced today a $100 million non-equity financing with an investment fund managed by Pharmakon Advisors and is hiring 250-300 specialty sales professionals for the launch of Vascepa for its initial indication, the MARINE indication, which is approved by the U.S. Food and Drug Administration (FDA).

Vitesse Semiconductor Corporation (Nasdaq: VTSS) 13.9% LOWER; announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock at a price to the public of $1.75 per share.

UniPixel, Inc. (Nasdaq: UNXL) 14.3% HIGHER; has joined forces with a manufacturer of personal computers to develop and introduce products that feature next-generation touch screens based on UniPixel's UniBoss" pro-cap, multi-touch sensor film.

JinkoSolar Holding Co., Ltd. (NYSE: JKS) 13.4% HIGHER; announced that JinkoSolar (Switzerland) AG, its Swiss subsidiary, has entered into a strategic cooperation agreement ("Strategic Cooperation Agreement") with the Guangdong Branch of China Development Bank pursuant to which CDB intends to provide financing cooperation to JinkoSolar (Switzerland) AG of an aggregate amount up to US$ 1 billion over a five-year period.

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX) 11.2% HIGHER; announced the pricing of its previously announced underwritten public offering of 12,500,000 shares of its common stock, offered at a price of $3.31 per share to the public.